BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21326311)

  • 1. Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients.
    Bhatnagar P; Purvis S; Barron-Casella E; DeBaun MR; Casella JF; Arking DE; Keefer JR
    J Hum Genet; 2011 Apr; 56(4):316-23. PubMed ID: 21326311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of variants at BCL11A and HBS1L-MYB with hemoglobin F and hospitalization rates among sickle cell patients in Cameroon.
    Wonkam A; Ngo Bitoungui VJ; Vorster AA; Ramesar R; Cooper RS; Tayo B; Lettre G; Ngogang J
    PLoS One; 2014; 9(3):e92506. PubMed ID: 24667352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
    Lettre G; Sankaran VG; Bezerra MA; Araújo AS; Uda M; Sanna S; Cao A; Schlessinger D; Costa FF; Hirschhorn JN; Orkin SH
    Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11869-74. PubMed ID: 18667698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia.
    Sebastiani P; Farrell JJ; Alsultan A; Wang S; Edward HL; Shappell H; Bae H; Milton JN; Baldwin CT; Al-Rubaish AM; Naserullah Z; Al-Muhanna F; Alsuliman A; Patra PK; Farrer LA; Ngo D; Vathipadiekal V; Chui DH; Al-Ali AK; Steinberg MH
    Blood Cells Mol Dis; 2015 Mar; 54(3):224-30. PubMed ID: 25703683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease.
    Liu L; Pertsemlidis A; Ding LH; Story MD; Steinberg MH; Sebastiani P; Hoppe C; Ballas SK; Pace BS
    Exp Biol Med (Maywood); 2016 Apr; 241(7):706-18. PubMed ID: 27022141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants associated with fetal hemoglobin levels show the diverse ethnic origin in Colombian patients with sickle cell anemia.
    Fong C; Menzel S; Lizarralde MA; Barreto G
    Biomedica; 2015; 35(3):437-43. PubMed ID: 26849705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies.
    Sedgewick AE; Timofeev N; Sebastiani P; So JCC; Ma ESK; Chan LC; Fucharoen G; Fucharoen S; Barbosa CG; Vardarajan BN; Farrer LA; Baldwin CT; Steinberg MH; Chui DHK
    Blood Cells Mol Dis; 2008; 41(3):255-258. PubMed ID: 18691915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between BCL11A, HSB1L-MYB, and XmnI γG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.
    El-Ghamrawy M; Yassa ME; Tousson AMS; El-Hady MA; Mikhaeil E; Mohamed NB; Khorshied MM
    Ann Hematol; 2020 Oct; 99(10):2279-2288. PubMed ID: 32772141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A candidate transacting modulator of fetal hemoglobin gene expression in the Arab-Indian haplotype of sickle cell anemia.
    Vathipadiekal V; Farrell JJ; Wang S; Edward HL; Shappell H; Al-Rubaish AM; Al-Muhanna F; Naserullah Z; Alsuliman A; Qutub HO; Simkin I; Farrer LA; Jiang Z; Luo HY; Huang S; Mostoslavsky G; Murphy GJ; Patra PK; Chui DH; Alsultan A; Al-Ali AK; Sebastiani P; Steinberg MH
    Am J Hematol; 2016 Nov; 91(11):1118-1122. PubMed ID: 27501013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Variants at BCL11A Erythroid-Specific Enhancer and Fetal Hemoglobin Levels among Sickle Cell Disease Patients in Cameroon: Implications for Future Therapeutic Interventions.
    Pule GD; Ngo Bitoungui VJ; Chetcha Chemegni B; Kengne AP; Antonarakis S; Wonkam A
    OMICS; 2015 Oct; 19(10):627-31. PubMed ID: 26393293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster.
    Solovieff N; Milton JN; Hartley SW; Sherva R; Sebastiani P; Dworkis DA; Klings ES; Farrer LA; Garrett ME; Ashley-Koch A; Telen MJ; Fucharoen S; Ha SY; Li CK; Chui DH; Baldwin CT; Steinberg MH
    Blood; 2010 Mar; 115(9):1815-22. PubMed ID: 20018918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia.
    Sales RR; Belisário AR; Faria G; Mendes F; Luizon MR; Viana MB
    Ann Hematol; 2020 Jul; 99(7):1453-1463. PubMed ID: 32447424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic determinants of HbF in Saudi Arabian and African Benin haplotype sickle cell anemia.
    Shaikho EM; Farrell JJ; Alsultan A; Sebastiani P; Steinberg MH
    Am J Hematol; 2017 Sep; 92(9):E555-E557. PubMed ID: 28612458
    [No Abstract]   [Full Text] [Related]  

  • 14. The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria.
    Ojewunmi OO; Adeyemo TA; Oyetunji AI; Inyang B; Akinrindoye A; Mkumbe BS; Gardner K; Rooks H; Brewin J; Patel H; Lee SH; Chung R; Rashkin S; Kang G; Chianumba R; Sangeda R; Mwita L; Isa H; Agumadu UN; Ekong R; Faruk JA; Jamoh BY; Adebiyi NM; Umar IA; Hassan A; Grace C; Goel A; Inusa BPD; Falchi M; Nkya S; Makani J; Ahmad HR; Nnodu O; Strouboulis J; Menzel S
    Hum Mol Genet; 2024 May; 33(10):919-929. PubMed ID: 38339995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil.
    Friedrisch JR; Sheehan V; Flanagan JM; Baldan A; Summarell CC; Bittar CM; Friedrisch BK; Wilke II; Ribeiro CB; Daudt LE; da Rocha Silla LM
    Blood Cells Mol Dis; 2016 Nov; 62():32-37. PubMed ID: 27838552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphic variations influencing fetal hemoglobin levels: association study in beta-thalassemia carriers and in normal individuals of Portuguese origin.
    Pereira C; Relvas L; Bento C; Abade A; Ribeiro ML; Manco L
    Blood Cells Mol Dis; 2015 Apr; 54(4):315-20. PubMed ID: 25842369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. rs11886868 and rs4671393 of BCL11A associated with HbF level variation and modulate clinical events among sickle cell anemia patients.
    Chaouch L; Moumni I; Ouragini H; Darragi I; Kalai M; Chaouachi D; Boudrigua I; Hafsia R; Abbes S
    Hematology; 2016 Aug; 21(7):425-9. PubMed ID: 27077760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetics of hemoglobin A2 regulation in sickle cell anemia.
    Griffin PJ; Sebastiani P; Edward H; Baldwin CT; Gladwin MT; Gordeuk VR; Chui DH; Steinberg MH
    Am J Hematol; 2014 Nov; 89(11):1019-23. PubMed ID: 25042611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans.
    Bae HT; Baldwin CT; Sebastiani P; Telen MJ; Ashley-Koch A; Garrett M; Hooper WC; Bean CJ; Debaun MR; Arking DE; Bhatnagar P; Casella JF; Keefer JR; Barron-Casella E; Gordeuk V; Kato GJ; Minniti C; Taylor J; Campbell A; Luchtman-Jones L; Hoppe C; Gladwin MT; Zhang Y; Steinberg MH
    Blood; 2012 Aug; 120(9):1961-2. PubMed ID: 22936743
    [No Abstract]   [Full Text] [Related]  

  • 20. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia.
    Uda M; Galanello R; Sanna S; Lettre G; Sankaran VG; Chen W; Usala G; Busonero F; Maschio A; Albai G; Piras MG; Sestu N; Lai S; Dei M; Mulas A; Crisponi L; Naitza S; Asunis I; Deiana M; Nagaraja R; Perseu L; Satta S; Cipollina MD; Sollaino C; Moi P; Hirschhorn JN; Orkin SH; Abecasis GR; Schlessinger D; Cao A
    Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1620-5. PubMed ID: 18245381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.